142 related articles for article (PubMed ID: 14628995)
1. Atypical myxomatosis--virus isolation, experimental infection of rabbits and restriction endonuclease analysis of the isolate.
Psikal I; Smíd B; Rodák L; Valícek L; Bendová J
J Vet Med B Infect Dis Vet Public Health; 2003 Aug; 50(6):259-64. PubMed ID: 14628995
[TBL] [Abstract][Full Text] [Related]
2. Rapid identification of myxoma virus variants by long-range PCR and restriction fragment length polymorphism analysis.
Dalton KP; Ringleb F; Martín Alonso JM; Parra F
J Virol Methods; 2009 Nov; 161(2):284-8. PubMed ID: 19591871
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of atypical myxomatosis in Central Europe: clinical and virological examinations.
Farsang A; Makranszki L; Dobos-Kovács M; Virág G; Fábián K; Barna T; Kulcsár G; Kucsera L; Vetési F
Acta Vet Hung; 2003; 51(4):493-501. PubMed ID: 14680061
[TBL] [Abstract][Full Text] [Related]
4. Experimental infection of specific pathogen-free New Zealand White rabbits with five strains of amyxomatous myxoma virus.
Marlier D; Cassart D; Boucraut-Baralon C; Coignoul F; Vindevogel H
J Comp Pathol; 1999 Nov; 121(4):369-84. PubMed ID: 10542126
[TBL] [Abstract][Full Text] [Related]
5. Vaccination strategies against myxomavirus infections: are we really doing the best?
Marlier D
Tijdschr Diergeneeskd; 2010 Mar; 135(5):194-8. PubMed ID: 20334023
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of two vaccination schemes against experimental infection with a virulent amyxomatous or a virulent nodular myxoma virus strain.
Marlier D; Mainil J; Boucraut-Baralon C; Linden A; Vindevogel H
J Comp Pathol; 2000; 122(2-3):115-22. PubMed ID: 10684680
[TBL] [Abstract][Full Text] [Related]
7. Monitoring the spread of myxoma virus in rabbit Oryctolagus cuniculus populations on the southern tablelands of New South Wales, Australia. II. Selection of a strain of virus for release.
Kerr PJ; Merchant JC; Silvers L; Hood GM; Robinson AJ
Epidemiol Infect; 2003 Feb; 130(1):123-33. PubMed ID: 12613754
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of SG33 and Borghi vaccines used against myxomatosis.
Cavadini P; Botti G; Barbieri I; Lavazza A; Capucci L
Vaccine; 2010 Jul; 28(33):5414-20. PubMed ID: 20598407
[TBL] [Abstract][Full Text] [Related]
9. Vaccine breaks: Outbreaks of myxomatosis on Spanish commercial rabbit farms.
Dalton KP; Nicieza I; de Llano D; Gullón J; Inza M; Petralanda M; Arroita Z; Parra F
Vet Microbiol; 2015 Aug; 178(3-4):208-16. PubMed ID: 26009303
[TBL] [Abstract][Full Text] [Related]
10. The α2,3-sialyltransferase encoded by myxoma virus is a virulence factor that contributes to immunosuppression.
Boutard B; Vankerckhove S; Markine-Goriaynoff N; Sarlet M; Desmecht D; McFadden G; Vanderplasschen A; Gillet L
PLoS One; 2015; 10(2):e0118806. PubMed ID: 25705900
[TBL] [Abstract][Full Text] [Related]
11. [Administration of vaccine against myxomatosis using live MXT by means of external ear puncture with a special needle].
Cupera Z; Krupka V; Jiran E
Vet Med (Praha); 1982; 27(10):617-26. PubMed ID: 6815860
[TBL] [Abstract][Full Text] [Related]
12. Monitoring the spread of myxoma virus in rabbit Oryctolagus cuniculus populations on the southern tablelands of New South Wales, Australia. I. Natural occurrence of myxomatosis.
Merchant JC; Kerr PJ; Simms NG; Robinson AJ
Epidemiol Infect; 2003 Feb; 130(1):113-21. PubMed ID: 12613753
[TBL] [Abstract][Full Text] [Related]
13. Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits.
Mossman K; Nation P; Macen J; Garbutt M; Lucas A; McFadden G
Virology; 1996 Jan; 215(1):17-30. PubMed ID: 8553583
[TBL] [Abstract][Full Text] [Related]
14. Coevolution of host and virus: the pathogenesis of virulent and attenuated strains of myxoma virus in resistant and susceptible European rabbits.
Best SM; Kerr PJ
Virology; 2000 Feb; 267(1):36-48. PubMed ID: 10648181
[TBL] [Abstract][Full Text] [Related]
15. Myxoma virus in the European rabbit: interactions between the virus and its susceptible host.
Stanford MM; Werden SJ; McFadden G
Vet Res; 2007; 38(2):299-318. PubMed ID: 17296158
[TBL] [Abstract][Full Text] [Related]
16. Disruption of M-T5, a novel myxoma virus gene member of poxvirus host range superfamily, results in dramatic attenuation of myxomatosis in infected European rabbits.
Mossman K; Lee SF; Barry M; Boshkov L; McFadden G
J Virol; 1996 Jul; 70(7):4394-410. PubMed ID: 8676463
[TBL] [Abstract][Full Text] [Related]
17. Expression of rabbit IL-4 by recombinant myxoma viruses enhances virulence and overcomes genetic resistance to myxomatosis.
Kerr PJ; Perkins HD; Inglis B; Stagg R; McLaughlin E; Collins SV; Van Leeuwen BH
Virology; 2004 Jun; 324(1):117-28. PubMed ID: 15183059
[TBL] [Abstract][Full Text] [Related]
18. Detection of myxoma viruses encoding a defective M135R gene from clinical cases of myxomatosis; possible implications for the role of the M135R protein as a virulence factor.
Belsham GJ; Polacek C; Breum SØ; Larsen LE; Bøtner A
Virol J; 2010 Jan; 7():7. PubMed ID: 20078890
[TBL] [Abstract][Full Text] [Related]
19. Partial sequencing of recent Portuguese myxoma virus field isolates exhibits a high degree of genetic stability.
Muller A; Silva E; Abrantes J; Esteves PJ; Ferreira PG; Carvalheira JC; Nowotny N; Thompson G
Vet Microbiol; 2010 Jan; 140(1-2):161-6. PubMed ID: 19709821
[TBL] [Abstract][Full Text] [Related]
20. Genome sequence of SG33 strain and recombination between wild-type and vaccine myxoma viruses.
Camus-Bouclainville C; Gretillat M; Py R; Gelfi J; Guérin JL; Bertagnoli S
Emerg Infect Dis; 2011 Apr; 17(4):633-8. PubMed ID: 21470452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
